Coverage
Filings
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 22 Jan 2009 |
| GROUP FINANCIAL STATEMENT FOR 2008 | 22 Jan 2009 |
| Financial calendar 2009 | 26 Nov 2008 |
| Group financial statement for the first nine months of 2008 | 31 Oct 2008 |
| Change in Novozymes's board | 31 Oct 2008 |